Differentiated Thyroid Cancer (chronic/survivorship)
Differentiated Thyroid Cancer (chronic/survivorship) is indexed under Oncologic-Adjacent Chronic, Endocrine Neoplasm. Also known as papillary thyroid cancer, follicular thyroid cancer, DTC.
- US prevalence
- SEER estimates 1,035,274 people were living with thyroid cancer in the U.S. in 2023; this includes all thyroid cancer histologies and must not be treated as a differentiated-thyroid-cancer-only prevalence Source: NCI SEER Cancer Stat Facts — Thyroid Cancer. This figure comes from a professional society, registry, or study rather than a federal source. Label: REPORTED.
- ICD-10-CM codes
- C73
- Typical onset
- Peak 30-50; papillary most common
- Course
- managed
- Body systems
- endocrine
- Sex differences
- F:M ~3:1
- Racial and ethnic differences
- Incidence increasing across all groups
What this page does not establish
These figures describe populations, not individuals, and none of them is a diagnosis or a treatment recommendation. Prevalence estimates are approximate and reflect published ranges. Disparity figures are reported patterns, not causes.
Taxonomy last reviewed 2026-05-19. Each figure on the interactive page carries its own source and retrieval date, which can be later than this review.
Browse all indexed conditions · Source registry · Methodology · Known limitations